October 31, 2023 02:31 PM EDTUpdated November 3, 06:51 AM
Pharma
Law

Nos­trum agrees to $50M set­tle­ment with DOJ over al­le­ga­tions of un­der­pay­ing Med­ic­aid

Katherine Lewin

News Reporter

Mis­souri-based phar­ma Nos­trum Lab­o­ra­to­ries and its CEO have agreed to pay a min­i­mum $3.8 mil­lion and up to $50 mil­lion to set­tle ac­cu­sa­tions from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­gen of­fers to buy out strug­gling neu­ro part­ner Sage Ther­a­peu­tics

Chas­ing the next wave of obe­si­ty drugs, Met­sera files for an IPO

Ex­clu­sive: Mod­er­na's for­mer top sci­en­tist has a new start­up us­ing AI to im­prove mR­NA ther­a­pies

Four biotechs emerge with $800M and in-li­censed as­sets on Fri­day

Up­dat­ed: CDER Di­rec­tor Pa­trizia Cavaz­zoni to step down ahead of Trump pres­i­den­cy

Lil­ly fi­nances new $500M biotech fund man­aged by a16z

A service from the Financial Times